首页> 美国卫生研究院文献>other >BAFF- and APRIL-dependent maintenance of Ab titers after immunization with T-dependent Ag and CD1d-binding ligand
【2h】

BAFF- and APRIL-dependent maintenance of Ab titers after immunization with T-dependent Ag and CD1d-binding ligand

机译:用T依赖的Ag和CD1d结合配体免疫后BAFF和APRIL依赖的抗体效价的维持

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

CD1d-restricted invariant Natural Killer T (iNKT) cells boost humoral immunity to T-dependent Ags that are co-administered with the CD1d-binding glycolipid Ag α-galactosylceramide (α-GC). Observations that mice lacking iNKT cells have decaying Ab responses following vaccination has led to the hypothesis that iNKT cells express plasma cell (PC) survival factors that sustain specific Ab titers. Bone marrow (BM) chimeric mice in which the entire hematopoetic compartment or iNKT cells selectively lacked BAFF, APRIL, or both BAFF and APRIL were created and immunized with NP-KLH adsorbed to Alum or mixed with α-GC. In comparison to BAFF- or APRIL-sufficient BM chimeras, absence of hematopoetic compartment- and iNKT-derived BAFF and APRIL was associated with rapidly decaying Ab titers and reduced PC numbers. The iNKT cell-derived BAFF or APRIL assumed a greater role in PC survival when α-GC was used as the adjuvant for immunization. These results show that iNKT-derived BAFF and APRIL each contribute to survival of PCs induced by immunization. This study sheds new light on the mechanisms through which iNKT cells impact humoral immunity and may inform design of vaccines that incorporate glycolipid adjuvants.
机译:CD1d限制不变的自然杀伤T细胞(iNKT)增强了对与CD1d结合的糖脂Agα-半乳糖基神经酰胺(α-GC)共同施用的T依赖性Ags的体液免疫。观察到缺乏iNKT细胞的小鼠在接种疫苗后具有减弱的Ab反应,这导致了iNKT细胞表达维持特定Ab滴度的浆细胞(PC)生存因子的假说。产生其中整个造血区室或iNKT细胞选择性缺乏BAFF,APRIL或BAFF和APRIL的骨髓(BM)嵌合小鼠,并用吸附于明矾或与α-GC混合的NP-KLH进行免疫。与BAFF或APRIL足够的BM嵌合体相比,造血区室和iNKT衍生的BAFF和APRIL的缺乏与Ab滴度迅速下降和PC数减少有关。当将α-GC用作免疫佐剂时,源自iNKT细胞的BAFF或APRIL在PC存活中起着更大的作用。这些结果表明,来自iNKT的BAFF和APRIL各自有助于免疫诱导的PC的存活。这项研究为iNKT细胞影响体液免疫的机制提供了新的思路,并可能为掺入糖脂佐剂的疫苗设计提供依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号